MERS vaccine safe and immunogenic in first-in-human trial
A DNA vaccine for MERS-CoV was demonstrated to be well-tolerated and immunogenic in a Phase I, first-in-human trial.
Browsing: MERS
Emerging technologies to investigate coronavirus emergence – an interview with Vineet Menachery
In this interview we speak to Vineet Menachery about his recent talk at the Microbiology Society’s Annual Conference (8–11 April, Belfast, UK) suggesting that CoV emergence is more complicated than receptor binding alone.
MERS-CoV case confirmed in England
Public Health England have confirmed that an individual has been diagnosed with MERS in England
Case of MERS reported in the United Arab Emirates
A case of Middle East Respiratory Syndrome has been reported to the WHO by the United Arab Emirates.
The next pandemic – priorities for prevention
Editor, Martha Powell, takes a closer look at MERS, Nipah and Lassa; considering their impact on populations thus far and why medical countermeasures against them are so urgently required.